Item 2.01. Completion of Acquisition or Disposition of Assets.

On February 15, 2022, Independence Holding Company, a Delaware corporation (the "Company"), completed the merger contemplated by the Agreement and Plan of Merger (the "Merger Agreement"), dated November 9, 2021, by and among the Company, Geneve Holdings, Inc., a Delaware corporation ("Geneve"), and Geneve Acquisition Corp., a Delaware corporation and indirect wholly-owned subsidiary of Geneve ("Merger Sub"), pursuant to which Merger Sub was merged with and into the Company, with the Company continuing as the surviving corporation after the merger (the "Merger"). As of December 31, 2021, Geneve was the indirect holder of approximately 62% of the issued and outstanding shares of common stock of the Company, par value $1.00 per share ("Common Stock").

Effect of the Merger on the Company Common Stock

At the effective time of the Merger (the "Effective Time"), each issued and outstanding share of Common Stock (other than certain excluded shares as described in the next sentence) was cancelled and converted into the right to receive $57.00 in cash, without interest (the "Merger Consideration"). In addition, at the Effective Time, (i) shares of Common Stock owned by Geneve and its wholly-owned subsidiaries (collectively, the "Geneve Group") were cancelled without payment of any consideration, (ii) shares of Common Stock owned or held in treasury by the Company or any of its wholly-owned subsidiaries were cancelled without payment of any consideration, and (iii) shares of Common Stock held by any holder of record of Common Stock who did not vote in favor of the Merger and was entitled to demand, and before the taking of the vote on the Merger validly demanded, appraisal of such shares pursuant to, and in accordance with, Section 262 of the Delaware General Corporation Law (the "DGCL", and such shares, the "Dissenting Shares") were cancelled and converted into the right to receive payment of such amounts that are payable in accordance with Section 262 of the DGCL and do not have the right to receive the Merger Consideration unless and until such holder loses, waives or withdraws its rights as a dissenting Company stockholder.

Treatment of Company Equity Awards

At the Effective Time:

·each outstanding option to purchase shares of Common Stock ("Stock Option") granted under the Company's 2016 Stock Incentive Plan, as amended (the "2016 Plan") (whether vested or unvested), was cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time and (ii) the excess, if any, of (x) the Merger Consideration of $57.00 per share over (y) the exercise price per share of such Stock Option, less applicable taxes required to be withheld with respect to such payment;

·each outstanding stock appreciation right ("SAR") granted under the 2016 Plan was cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the number of shares of Common Stock linked to such SAR immediately prior to the Effective Time and (ii) the excess of (x) the Merger Consideration of $57.00 per share over (y) the exercise price per share linked to such SAR, less applicable taxes required to be withheld with respect to such payment; and

--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

·each outstanding restricted stock unit ("RSU") granted under the 2016 Plan, . . .

Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

The information set forth in Item 2.01 of this report is incorporated herein by reference.

Prior to the close of trading on February 15, 2022, in connection with the consummation of the Merger, the Company notified the NYSE that the Merger had been consummated and requested that the trading of the Common Stock on the NYSE be suspended before market open on February 16, 2022 and that the listing of the Common Stock on the NYSE be withdrawn. In addition, the Company requested that the NYSE file with the Securities and Exchange Commission (the "SEC") a notification on Form 25 of the removal from listing of the Common Stock on the NYSE and the removal of registration of the Common Stock under Section 12(b) of the Securities Exchange Act of 1934, as amended (the "Exchange Act").

--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

The Company also intends to file with the SEC, at the time such filing is permitted under SEC rules, a certification and notice on Form 15 of termination of registration of the Common Stock under Section 12(g) of the Exchange Act and suspension of the Company's duty to file reports under Sections 13 and 15(d) of the Exchange Act.

Item 3.03. Material Modifications to Rights of Security Holders.

The information set forth in Items 2.01 and 3.01 of this report is incorporated herein by reference.

At the Effective Time, the Company's stockholders immediately before the Effective Time ceased to have any rights in the Company as stockholders, other than their right to receive (i) the Merger Consideration (other than the Geneve Group) or, with respect to stockholders holding Dissenting Shares, appraisal rights, and (ii) the Final Dividend.

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

The information set forth in Item 2.01 of this report is incorporated herein by reference.

In connection with the consummation of the Merger, Steven B. Lapin, the sole director of Merger Sub immediately prior to the Effective Time, became the initial director of the surviving corporation. Accordingly, as of the Effective Time, each of Vincent Furfaro, Larry R. Graber, Teresa A. Herbert, Allan C. Kirkman, John L. Lahey, Steven B. Lapin, Ronald I. Simon, James G. Tatum and Roy T.K. Thung ceased to serve as a director of the Company.

Also, at the Effective Time, the officers of the Company immediately prior to the Effective Time became the initial officers of the surviving corporation.

Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

The information set forth in Item 2.01 of this report is incorporated herein by reference.

Effective upon completion of the Merger, the Company's certificate of incorporation and bylaws, as in effect immediately prior to the Effective Time, were amended and restated in their entirety as contemplated by the Merger Agreement. The full text of the Third Amended and Restated Certificate of Incorporation of the Company and Amended and Restated Bylaws of the Company are filed as Exhibit 3.1 and Exhibit 3.2, respectively, to this report and are incorporated herein by reference.

Item 5.07. Submission of Matters to a Vote of Security Holders.

The information set forth in Item 2.01 of this report is incorporated herein by reference.

Pursuant to the Merger Agreement and applicable law, the approval of the proposal to adopt the Merger Agreement required the approval of both (i) holders of a majority of the issued and outstanding shares of Common Stock at the close of business on January 3, 2022 (the "Record Date", and such vote, the "Company Stockholder Vote") and (ii) holders of a majority of the issued and outstanding shares of Common Stock at the close of business on the Record Date, other than

--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

shares of Common Stock held by the Geneve Group or beneficially owned by any affiliate of Geneve (such vote, the "Unaffiliated Stockholder Vote").

On February 15, 2022, the proposal to adopt the Merger Agreement was approved at a special meeting of stockholders of the Company (the "Special Meeting").

According to the report of the inspector of elections, at the Special Meeting, the proposal to adopt the Merger Agreement was approved by (i) approximately 90.40% of the issued and outstanding shares of Common Stock at the close of business on the Record Date and (ii) approximately 72.89% of the issued and outstanding shares of Common Stock at the close of business on the Record Date, other than shares of Common Stock held by the Geneve Group or beneficially owned by any affiliate of Geneve. A proposal to adjourn the Special Meeting, if necessary or appropriate, to solicit additional proxies, was not needed because there were sufficient votes to approve the proposal to adopt the Merger Agreement.

The tally of the votes for the Company Stockholder Vote is as follows:



   FOR       AGAINST   ABSTAIN   BROKER NON-VOTES
13,344,120   39,868     7,000           0



The tally of the votes for the Unaffiliated Stockholder Vote is as follows:



   FOR      AGAINST   ABSTAIN   BROKER NON-VOTES
3,808,836   39,868     7,000           0



In addition, at the Special Meeting, the non-binding, advisory proposal to approve certain compensation arrangements for the Company's named executive officers in connection with the Merger (the "Compensation Proposal") was approved by approximately 80.54% of the shares of Common Stock present or represented by proxy at the Special Meeting and entitled to vote thereon.

The tally of the votes for the Compensation Proposal is as follows:



   FOR        AGAINST    ABSTAIN   BROKER NON-VOTES
11,888,688   1,251,069   251,231          0


Item 8.01 Other Events.

On February 15, 2022, the Company issued a press release announcing the completion of the Merger. A copy of the press release is filed as Exhibit 99.1 to this report and is incorporated herein by reference.

--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

Item 9.01. Financial Statements and Exhibits.

(d)

Exhibit 2.1. Agreement and Plan of Merger, dated November 9, 2021, by and among Independence Holding Company, Geneve Holdings, Inc. and Geneve Acquisition Corp. (Filed as Appendix A to the PREM 14A filed by Independence Holding Company on November 24, 2021 and incorporated herein by reference).

Exhibit 3.1. Third Amended and Restated Certificate of Incorporation of Independence Holding Company . *



  Exhibit 3.2.     Amended and Restated By-laws of Independence Holding
Company    .  *

  Exhibit 99.1.     Press Release  .*

* Filed herewith.

© Edgar Online, source Glimpses